Intravenous Iron Therapy Market

Iron is considered as an essential element which plays an important role in many vital biological processes such as the formation of myoglobin, neurotransmitter production, energy metabolism, the formation of collagen and immune system function, and others.Intravenous Iron Therapy is usually preferred over oral iron therapy. This is majorly due to the advantages of intravenous iron therapy, such as faster and higher increase in hemoglobin (Hb) levels and replenishment of body iron stores.
Intravenous Iron Therapy Market contains market size and forecasts of Intravenous Iron Therapy in Global, including the following market information:
Global Intravenous Iron Therapy Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Intravenous Iron Therapy market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Iron Sucrose Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Intravenous Iron Therapy include American Regent, Inc., AMAG Pharmaceuticals, Inc, Fresenius Medical Care, Actavis Pharma, Inc. and Sanofi S.A., etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Intravenous Iron Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Intravenous Iron Therapy Market, by Treatment Type, 2017-2022, 2023-2028 ($ millions)
Global Intravenous Iron Therapy Market Segment Percentages, by Treatment Type, 2021 (%)
Iron Sucrose
Ferric Gluconate
Ferric Carboxymaltose
Ferumoxytol
Others
Global Intravenous Iron Therapy Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Intravenous Iron Therapy Market Segment Percentages, by Application, 2021 (%)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Others
Global Intravenous Iron Therapy Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Intravenous Iron Therapy Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Intravenous Iron Therapy revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Intravenous Iron Therapy revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
American Regent, Inc.
AMAG Pharmaceuticals, Inc
Fresenius Medical Care
Actavis Pharma, Inc.
Sanofi S.A.